By Scientia Professor Matthew Colm Kiernan

Books

, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

Book Chapters

Park SB; Kiernan MC, 2023, 'Chemotherapy-Induced Cranial Nerve Damage', in The Cranial Nerves in Neurology: A comprehensive and systematic evaluation of cranial nerves, pathology and specific conditions, pp. 189 - 193, http://dx.doi.org/10.1007/978-3-031-43081-7_23

Vucic S; Kiernan MC, 2023, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Second Edition, pp. 1803 - 1821, http://dx.doi.org/10.1007/978-3-031-15080-7_138

Tu S; Kiernan MC, 2023, 'Amyotrophic lateral sclerosis', in Advances in Magnetic Resonance Technology and Applications, Elsevier, pp. 363 - 385, http://dx.doi.org/10.1016/b978-0-323-91771-1.00016-2

Vucic S; Kiernan MC, 2021, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Springer International Publishing, pp. 1 - 19, http://dx.doi.org/10.1007/978-3-030-71519-9_138-1

Dharmadasa T; Huynh W; Kiernan MC, 2020, 'Transcranial magnetic stimulation in the cortical exploration of dementia', in Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1, pp. 327 - 343, http://dx.doi.org/10.1016/B978-0-12-815854-8.00021-5

Huynh W; Lee M; Kiernan MC, 2020, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Dietz V; Ward NS; Kennard C (ed.), Oxford Textbook of Neurorehabilitation, Oxford University Press, pp. 253 - 268, http://dx.doi.org/10.1093/med/9780198824954.003.0019

Huynh W; Dharmadasa T; Agarwal S; Caga J; Kiernan MC, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918

Huynh W; Dharmadasa T; Agarwal S; Caga J; Kiernan MC, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, Routledge, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918-9

Hardiman O; Kiernan MC; van den Berg LH, 2016, 'Amyotrophic Lateral Sclerosis', in Neurodegenerative Disorders, Springer International Publishing, pp. 145 - 165, http://dx.doi.org/10.1007/978-3-319-23309-3_8

huynh W; lee M; kiernan MC, 2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press, USA, pp. 225 - 235

Kiernan MC, 2014, 'Impulse Conduction: Molecular Perspectives', in Encyclopedia of the Neurological Sciences, pp. 688 - 690, http://dx.doi.org/10.1016/B978-0-12-385157-4.00060-9

Vucic S; Kiernan MC, 2014, 'Neurotoxicity and ALS: Insights into pathogenesis', in Handbook of Neurotoxicity, pp. 1435 - 1456, http://dx.doi.org/10.1007/978-1-4614-5836-4_138

, 2013, 'Nerve Conduction Studies', in Encyclopedia of Pain, Springer Berlin Heidelberg, pp. 2024 - 2024, http://dx.doi.org/10.1007/978-3-642-28753-4_101376

Farrar M; Kiernan MC, 2011, 'Spinal Muscular Atrophy', in Encyclopedia of Life Sciences (eLS), John Wiley & Sons, Ltd., Chichester, pp. 1 - 7, http://dx.doi.org/10.1002/9780470015902.a0006011.pub2

Park SB; Kiernan MC, 2010, 'Biophysical Properties Underlying Human Nerve Impulse Conduction', in DuBois ML (ed.), Action Potential: Biophysical and Cellular Context, Initiation, Phases and Propagation, Nova Science Publishers, USA, pp. 29 - 63, https://www.novapublishers.com/catalog/product_info.php?cPath=23_483&products_id=14126&osCsid=36c853df640479f435610c963513f08b

Park SB; Kiernan MC, 2010, 'Chemotherapy-induced neurotoxicity', in Hayat MA (ed.), Methods of Cancer Diagnosis, Therapy and Prognosis. Volume 7, Springer, USA, pp. 99 - 119, http://www.springer.com/biomed/cancer/book/978-90-481-3185-3

Vucic O; Burke D; Kiernan MC, 2007, 'Diagnosis of motor nerone disease', in Kiernan M (ed.), The motor neurone disease handbook, Australasian Medical Publishing Company, Strawberry Hills, N.S.W., pp. 89 - 104

Kiernan MC, 2007, 'Oxaliplatin-induced neurotoxicity: New pathophysiological insights', in Webster LR (ed.), Neurotoxicity Syndromes, Nova Science Publications, New York, USA, pp. 169 - 181

Lin CS; Kiernan MC; Burke D; Bostock H, 2006, 'Assessment of nerve excitability properties in peripheral nerve disease', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 381 - 403

Burke D; Kiernan MC, 2006, 'Developments in the assessment of peripheral nerve function', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 927 - 943

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy: 2-Volume Set with Expert Consult Basic, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9

KIERNAN MC; BURKE D; BOSTOCK H, 2005, 'Chapter 5 Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy, Elsevier, pp. 113 - 129, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50008-9

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve excitability measures: Biophysical basis and use in the investigation of peripheral nerve disease', in Dyck PJ; Thomas PK (ed.), Peripheral Neuropathy, Elsevier Saunders, Unites States, pp. 113 - 129

Kiernan MC; Burke D, 2004, 'Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis', in Eisen A (ed.), Handbook of Clinical Neurophysiology. Volume 4: Clinical Neurophysiology of Motor Neurone Disease, Elsevier BV, The Netherlands, pp. 359 - 366

Kiernan MC, 2003, 'Impulse Conduction', in Encyclopedia of the Neurological Sciences: Volumes 1-4, pp. V2-639-V2-642, http://dx.doi.org/10.1016/B0-12-226870-9/02032-3

Kiernan MC, 2003, 'Impulse conduction', in Encyclopedia of the Neurological Sciences, Volume 2, Academic Press, San Diego, pp. 639 - 642

Burke DJ; Mogyoros I; Kiernan MC; Bostock H, 1997, 'Excitability of cutaneous sensory axons in amyotrophic lateralis sclerosis', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 145 - 154

Burke DJ; Kiernan MC; Mogyoros I; Bostock H, 1997, 'Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 43 - 53

Journal articles

Vucic S; Pavey N; Menon P; Babayev M; Maslyukova A; Muraviev A; Kiernan MC, 2025, 'Neurophysiological assessment of cortical motor function: A direct comparison of methodologies', Clinical Neurophysiology, 170, pp. 14 - 21, http://dx.doi.org/10.1016/j.clinph.2024.12.001

Tu S; Li T; Carroll AS; Mahoney CJ; Huynh W; Park SB; Henderson R; Vucic S; Kiernan MC; Lin CSY, 2024, 'Central neurodegeneration in Kennedy’s disease accompanies peripheral motor dysfunction', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-69393-5

J M Dick T; Tucker K; Hug F; Besomi M; van Dieën JH; Enoka RM; Besier T; Carson RG; Clancy EA; Disselhorst-Klug C; Falla D; Farina D; Gandevia S; Holobar A; Kiernan MC; Lowery M; McGill K; Merletti R; Perreault E; Rothwell JC; Søgaard K; Wrigley T; Hodges PW, 2024, 'Consensus for experimental design in electromyography (CEDE) project: Application of EMG to estimate muscle force', Journal of Electromyography and Kinesiology, 79, pp. 102910, http://dx.doi.org/10.1016/j.jelekin.2024.102910

van den Bos MAJ; Menon P; Pavey N; Higashihara M; Kiernan MC; Vucic S, 2024, 'Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis.', Brain, http://dx.doi.org/10.1093/brain/awae317

Timmins HC; Thompson AE; Kiernan MC, 2024, 'Diagnostic criteria for amyotrophic lateral sclerosis', Current Opinion in Neurology, 37, pp. 570 - 576, http://dx.doi.org/10.1097/WCO.0000000000001302

Kiernan MC; Kaji R, 2024, 'Emerging concepts and therapies for amyotrophic lateral sclerosis', Current Opinion in Neurology, 37, pp. 558 - 559, http://dx.doi.org/10.1097/WCO.0000000000001308

Tu S; Vucic S; Kiernan MC, 2024, 'Pathological insights derived from neuroimaging in amyotrophic lateral sclerosis: Emerging clinical applications', Current Opinion in Neurology, 37, pp. 577 - 584, http://dx.doi.org/10.1097/WCO.0000000000001295

Devenney EM; Anh N Nguyen Q; Tse NY; Kiernan MC; Tan RH, 2024, 'A scoping review of the unique landscape and challenges associated with dementia in the Western Pacific region', The Lancet Regional Health - Western Pacific, 50, http://dx.doi.org/10.1016/j.lanwpc.2024.101192

Timmins HC; Mok VCT; Kim SH; Shahrizaila N; Sung JY; Sobue G; Agustini S; Ward S; Anstey KJ; Talbot DL; Mazumder S; Tu S; Tan RH; Shin-Yi Lin C; O'Callaghan C; Michaelian JC; Jeon YH; Foxe D; Naismith SL; Piguet O; Ahmed R; Devenney E; Park SB; Kiernan MC, 2024, 'Regional health priorities for dementia: a roadmap for the Western Pacific', The Lancet Regional Health - Western Pacific, 50, http://dx.doi.org/10.1016/j.lanwpc.2024.101179

Clarke AJ; Brodtmann A; Irish M; Mowszowski L; Radford K; Naismith SL; Mok VCT; Kiernan MC; Halliday GM; Ahmed RM, 2024, 'Risk factors for the neurodegenerative dementias in the Western Pacific region', The Lancet Regional Health - Western Pacific, 50, http://dx.doi.org/10.1016/j.lanwpc.2024.101051

Li T; Timmins HC; Mahfouz FM; Trinh T; Mizrahi D; Horvath LG; Harrison M; Grimison P; Friedlander M; Marx G; Boyle F; Wyld D; Henderson R; King T; Baron-Hay S; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy', JAMA Network Open, 7, pp. e2424139, http://dx.doi.org/10.1001/jamanetworkopen.2024.24139

Rahiman K J, 2024, 'Chemotherapy-Induced Neurotoxicity', International Journal of Science and Research (IJSR), 13, pp. 1250 - 1254, http://dx.doi.org/10.21275/sr24820170848

Pavey NA; Menon P; Peterchev AV; Kiernan MC; Vucic S, 2024, 'Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis', Clinical Neurophysiology, 164, pp. 161 - 167, http://dx.doi.org/10.1016/j.clinph.2024.05.014

Pavey N; Hannaford A; Van Den Bos M; Kiernan MC; Menon P; Vucic S, 2024, 'Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis', Brain, 147, pp. 2344 - 2356, http://dx.doi.org/10.1093/brain/awae049

Gray E; Menadue C; Piper A; Wong K; Yee B; Kiernan M, 2024, 'Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry', ERJ Open Research, 10, http://dx.doi.org/10.1183/23120541.00927-2023

Dharmadasa T; Pavey N; Tu S; Menon P; Huynh W; Mahoney CJ; Timmins HC; Higashihara M; van den Bos M; Shibuya K; Kuwabara S; Grosskreutz J; Kiernan MC; Vucic S, 2024, 'Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter', Clinical Neurophysiology, 163, pp. 68 - 89, http://dx.doi.org/10.1016/j.clinph.2024.04.010

Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S, 2024, 'Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study', European Journal of Neurology, 31, http://dx.doi.org/10.1111/ene.16281

Besomi M; Devecchi V; Falla D; McGill K; Kiernan MC; Merletti R; van Dieën JH; Tucker K; Clancy EA; Søgaard K; Hug F; Carson RG; Perreault E; Gandevia S; Besier T; Rothwell JC; Enoka RM; Holobar A; Disselhorst-Klug C; Wrigley T; Lowery M; Farina D; Hodges PW, 2024, 'Consensus for experimental design in electromyography (CEDE) project: Checklist for reporting and critically appraising studies using EMG (CEDE-Check)', Journal of Electromyography and Kinesiology, 76, http://dx.doi.org/10.1016/j.jelekin.2024.102874

Li T; Timmins HC; Mahfouz FM; Mizrahi D; Horvath L; Harrison ML; Grimison PS; Friedlander M; Marx GM; Boyle FM; Wyld D; Henderson R; King T; Baron-Hay SE; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016

Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB, 2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5

Back to profile page